Impact of Conditioning Regimen and Graft-versus-Host Disease Prophylaxis on The Outcome of Haploidentical Peripheral Blood Stem Cell Transplantation for High-Risk Severe Aplastic Anemia in Children and Young Adults: A Report from the Pediatric Severe Aplastic Anemia Consortium of India

医学 内科学 氟达拉滨 移植 再生障碍性贫血 噻替帕 移植物抗宿主病 梅尔法兰 环磷酰胺 造血干细胞移植 布苏尔班 全身照射 养生 胃肠病学 外科 骨髓 化疗
作者
Gaurav Kharya,Sarita Rani Jaiswal,Sunil Bhat,Revathi Raj,Satya Prakash Yadav,Vikas Dua,Santanu Sen,Atish Bakane,Shobha Badiger,Ramya Uppuluri,Neha Rastogi,Mansi Sachdev,Bharti Sharma,Ashraf Saifullah,Suparno Chakrabarti
出处
期刊: [Elsevier BV]
卷期号:29 (3): 199.e1-199.e10 被引量:12
标识
DOI:10.1016/j.jtct.2022.12.010
摘要

Allogenic hematopoietic cell transplantation (HCT) is the best curative approach for patients with severe aplastic anemia (SAA). The outcomes of HCT from haploidentical family donors (HFDs) have improved, making it a feasible option for patients lacking an HLA-identical donor. However, data on HFD-HCT for younger patients with SAA is sparse. In this multicenter retrospective study, we evaluated the outcomes of 79 patients undergoing HFD-HCT for SAA. All the patients were heavily pretransfused, the median time to HCT was >12 months, and 67% had failed previous therapies. Conditioning was based on fludarabine (Flu)-cyclophosphamide (Cy)-antithymocyte globulin (ATG)/total body irradiation (TBI) with or without thiotepa/melphalan (TT/Mel). Post-transplantation Cy (PTCy) and calcineurin inhibitors (CNIs)/sirolimus were used as graft-versus-host disease (GVHD) prophylaxis with or without abatacept. The rate of primary graft failure (PGF) was 16.43% overall, lower in patients conditioned with TT/Mel. The incidences of acute and chronic GVHD were 26.4% and 18.9%, respectively. At a median follow-up of 48 months, the overall survival (OS) and event-free survival (EFS) were 61.6% and 58.1%, respectively. Both OS and EFS were better in the TT/Mel recipients and with abatacept as GVHD prophylaxis. On multivariate analysis, the use of abatacept was found to favorably impact the outcome variables, including GVHD and EFS. Our study suggests that PTCy-based HFD-HCT is a reasonable option for young patients with high-risk SAA, in whom optimization of conditioning and GVHD prophylaxis might further improve outcomes.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
1秒前
xuanxuan完成签到,获得积分10
2秒前
今夜有雨完成签到 ,获得积分10
4秒前
11关闭了11的文献求助
4秒前
在青云端拧瓶盖的哪吒完成签到,获得积分10
6秒前
Lyra完成签到 ,获得积分10
6秒前
胡心怡完成签到,获得积分20
7秒前
可爱的函函的应助被士多啤梨采纳,获得10
8秒前
wjw发布了新的文献求助10
9秒前
zmr123完成签到 ,获得积分10
9秒前
twh完成签到,获得积分10
14秒前
云隐发布了新的文献求助10
14秒前
潇潇雨歇发布了新的文献求助10
15秒前
15秒前
愉快雪柳关注了科研通微信公众号
16秒前
无花果的应助被zz采纳,获得10
17秒前
17秒前
科研通AI6.4的应助被YIDAN采纳,获得10
18秒前
18秒前
科研通AI6.3的应助被复杂达采纳,获得10
19秒前
20秒前
20秒前
ssh完成签到,获得积分10
22秒前
经十路以东的应助被e00ec采纳,获得20
22秒前
拜拜拜仁发布了新的文献求助10
23秒前
车访枫发布了新的文献求助10
24秒前
Owen的应助被chchjust采纳,获得10
24秒前
温凉完成签到,获得积分10
24秒前
24秒前
荷月三发布了新的文献求助10
24秒前
Neuron完成签到,获得积分10
26秒前
kiki完成签到 ,获得积分10
26秒前
乐空思的应助被Firewoods采纳,获得20
27秒前
SS完成签到 ,获得积分10
27秒前
一兜兜糖完成签到,获得积分10
28秒前
ubless607的应助被温凉采纳,获得10
28秒前
e00ec发布了新的文献求助10
28秒前
斯文败类的应助被yy采纳,获得10
30秒前
111发布了新的文献求助10
30秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 2000
Handbook of Sport Coaching Research 1000
Orthognathic Surgery - 2 Volume Set 500
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8194415
求助须知:如何正确求助?哪些是违规求助? 9580155
关于积分的说明 21870088
捐赠科研通 7793967
什么是DOI,文献DOI怎么找? 3437647
关于科研通互助平台的介绍 2560986
邀请新用户注册赠送积分活动 2484376